Advertisement

Journal of Pharmacokinetics and Biopharmaceutics

, Volume 17, Issue 5, pp 551–570 | Cite as

Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: Relationship of pharmacokinetics and pharmacodynamics

  • Michael Corbo
  • Pei-Ran Wang
  • John K-J Li
  • Yie W. Chien
Article

Abstract

Myocardial contractility of normotensive and spontaneously hypertensive rabbits was determined following an iv bolus injection of propranolol HCl. Left ventricular pressure and dimension were used to calculate the contractility parameters of (dP/dt) max ,maximum fiber shortening velocity V cf , and the slope of the end systolic pressure-end systolic volume line (ESP-ESV line). Hypertension was induced by a methoxamine HCl iv infusion which mimicked the cardiac effects seen in essential hypertension. Propanolol caused a significant decrease in all contractility parameters (p<0.05)within 15min after administration, with a peak effect occurring after 30–35 mins. The pharmacokinetics and pharmacodynamics of propranolol were fit using Hill's equation in conjunction with the concentration of drug in the theoretical effect compartment. The normotensive group of rabbits had a calculated EC (50) of 12.7 ng/ml, while the hypertensive group had an EC 50 of 6.9 ng/ml,indicating that the hypertensive rabbits were much more sensitive to the propranolol than the normotensive group. In addition, the normotensive group of rabbits demonstrated a much different pharmacokinetic-pharmacodynamic relationship than that of the hypertensive group, indicating that the hypertensive state of the animal has a significant effect upon the concentration-effect relationship.

Key words

propranolol pharmacokinetics pharmacodynamics myocardial contractility hypertensive rabbit 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. Robin, C. Cowan, P. Puri, S. Ganguly, E. DeBoyrie, M. Martinez, T. Stock, and R. J. Bing. A comparative study of nitroglycerine and propranolol.Circulation 36:175–186 (1967).PubMedCrossRefGoogle Scholar
  2. 2.
    R.H. Helfant, M. V. Herman and R. Gorlin, Abnormalities of the left ventricular contraction induced by beta blockade.Circulation 43:641–647 (1971).PubMedCrossRefGoogle Scholar
  3. 3.
    L. B. Sheiner, D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine.Clin. Pharmacol. Ther. 25: 358–269 (1979).PubMedGoogle Scholar
  4. 4.
    W. A. Colburn. Simultaneous pharmacokinetic and pharmacodynamic modeling.J. Pharmacokin. Biopharm. 9:367–387 (1981).CrossRefGoogle Scholar
  5. 5.
    N. H. G. Holford and L. B. Sheiner. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models.Clin. Pharmacokin. 6:429–453 (1981).CrossRefGoogle Scholar
  6. 6.
    J. K-J Li. Regional ventricular function in myocardial ischemia. In S. Sideman and R. Beyar (eds.),Activation, Metabolism and Perfusion of the Heart, Martinus Nijhoff, The Hague, 1987.Google Scholar
  7. 7.
    E. Braunwald, J. Ros, and E. Sonenblick.Mechanism of Contraction of the Normal and Failing Heart, Little, Brown & Co., Boston, 1976.Google Scholar
  8. 8.
    E. Kwong and D. D. Shen. Versatile isocratic high-performance liquid chromatography assay for propranolol and its basic, neutral and acidic metabolites in biological fluids.J. Chromatogr. 414:365–397 (1987).PubMedCrossRefGoogle Scholar
  9. 9.
    M. A. D. H. Schalekamp and G. J. Wenting. Mechanism of antihypertensive action of kertenserin in man.Br. Med. J. 287: 1300–1301 (1983).CrossRefGoogle Scholar
  10. 10.
    F. Mahler, J. Covell, and J. Ross, Systolic pressure-diameter relations in normal conscious dog.Cardiovasc. Res. 9: 447–455 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    K. Sagawa, H. Suga, A. A. Shoukas, and K. M. Bakalar. End-systolic pressure/volume ratio: A new index of ventricular contractility.Am. J. Cardiol. 40: 748–753 (1977).PubMedCrossRefGoogle Scholar
  12. 12.
    A. Wellstein, D. Palm, G. G. Belz, and H. F. Pitschner. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effect of beta blockers,Arzneim. Forsch. 35:2–6 (1985).Google Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Michael Corbo
    • 1
  • Pei-Ran Wang
    • 1
  • John K-J Li
    • 2
  • Yie W. Chien
    • 1
  1. 1.Controlled Drug-Delivery Research CenterRutgers University College of PharmacyPiscataway
  2. 2.Cardiovascular Research Laboratory, Department of Biomedical EngineeringRutgers UniversityPiscataway

Personalised recommendations